Leslie Trigg - 07 Mar 2025 Form 4 Insider Report for Outset Medical, Inc. (OM)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
11 Mar 2025, 16:32:39 UTC
Prior SEC filing
19 Feb 2025
Next SEC filing
01 May 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: John L Brottem For: Leslie Trigg

Key filing fact

Leslie Trigg filed Form 4 for Outset Medical, Inc. (OM) on 11 Mar 2025.

Key facts

  • This page summarizes Leslie Trigg's Form 4 filing for Outset Medical, Inc. (OM).
  • 3 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 11 Mar 2025, 16:32.

Change

  • Previous filing in this sequence was filed on 19 Feb 2025.
  • Current net transaction value: +$500,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OM transaction

Common Stock

Options Exercise

Transaction value
Shares
+625,000
Change %
Price
Shares after
625,000
Date
10 Mar 2025
Ownership
Trigg 2002 Rev Trust
Footnotes
F1
OM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
880,969
Date
07 Mar 2025
Ownership
Direct
OM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
8,770
Date
07 Mar 2025
Ownership
Trigg Family Trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OM transaction Derivative

Series A Non-Voting Convertible Preferred

Award

Transaction value
$500,000
Shares
+2,500
Change %
Price
$200.00
Shares after
2,500
Date
07 Mar 2025
Ownership
Trigg 2002 Rev Trust
Underlying class
Preferred Stock
Underlying amount
2,500
Exercise price
$0.000000
Footnotes
F2
OM transaction Derivative

Series A Non-Voting Convertible Preferred

Options Exercise

Transaction value
$0
Shares
-2,500
Change %
-100%
Price
$0.000000
Shares after
0
Date
10 Mar 2025
Ownership
Trigg 2002 Rev Trust
Underlying class
Preferred Stock
Underlying amount
2,500
Exercise price
$0.000000
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its Meeting of Stockholders, held on March 5, 2025, after which each share of Preferred Stock automatically converted into 250 shares of Common Stock on March 10, 2025.

Footnote F2

These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .